These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1361568)

  • 1. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat.
    Correa-Sales C; Nacif-Coelho C; Reid K; Maze M
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat.
    Rabin BC; Guo TZ; Maze M
    Pharmacol Biochem Behav; 1997; 57(1-2):23-9. PubMed ID: 9164550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine.
    Reid K; Guo TZ; Davies MF; Maze M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat.
    Nacif-Coelho C; Correa-Sales C; Chang LL; Maze M
    Anesthesiology; 1994 Dec; 81(6):1527-34. PubMed ID: 7992922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats.
    Correa-Sales C; Rabin BC; Maze M
    Anesthesiology; 1992 Jun; 76(6):948-52. PubMed ID: 1350889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertussis toxin-mediated ribosylation of G proteins blocks the hypnotic response to an alpha 2-agonist in the locus coeruleus of the rat.
    Correa-Sales C; Reid K; Maze M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):723-7. PubMed ID: 1360160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.
    Mizobe T; Maghsoudi K; Sitwala K; Tianzhi G; Ou J; Maze M
    J Clin Invest; 1996 Sep; 98(5):1076-80. PubMed ID: 8787667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypnotic and analgesic effects of the alpha 2-adrenergic agonist dexmedetomidine in morphine-tolerant rats.
    Hayashi Y; Guo TZ; Maze M
    Anesth Analg; 1996 Sep; 83(3):606-10. PubMed ID: 8780290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
    Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
    Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct.
    Rouch AJ; Kudo LH; Hébert C
    J Pharmacol Exp Ther; 1997 Apr; 281(1):62-9. PubMed ID: 9103481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
    Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
    Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS; Tallman JF; Nestler EJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
    Bol CJJG ; Danhof M; Stanski DR; Mandema JW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel action of morphine in the rat locus coeruleus: persistent decrease in adenylate cyclase.
    Beitner DB; Duman RS; Nestler EJ
    Mol Pharmacol; 1989 May; 35(5):559-64. PubMed ID: 2498635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channels are involved in the hypnotic-anesthetic action of dexmedetomidine in rats.
    Horvàth G; Szikszay M; Benedek G
    Anesth Analg; 1992 Jun; 74(6):884-8. PubMed ID: 1375817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.
    Vulliemoz Y; Whittington RA; Virag L
    Brain Res; 1999 Dec; 849(1-2):169-74. PubMed ID: 10592299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.